共 50 条
- [32] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer - The Movsas article reviewed [J]. ONCOLOGY-NEW YORK, 2002, 16 (01): : 105 - 106
- [35] Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 509 - 512
- [36] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 53 - 59
- [38] Radiotherapy for patients with completely resected pathologic IIIA(N2) non-small-cell lung cancer: a retrospective analysis [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10901 - 10908
- [39] Combination of docetaxel and gemcitabine effective in non-small-cell lung cancer [J]. ONCOLOGY-NEW YORK, 2001, 15 (02): : 186 - 186
- [40] A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (06) : 783 - 790